AI Stock Picks — S&P 500

Thursday, September 24, 2026  ·  Five AI analysts screened this index for stocks with the best shot at gaining +5% within 30 days

Today's Market Mood

Neutral  Normal choppiness · VIX 15.8

The broader S&P 500 is in a sharp, widespread drawdown, with most constituents down double digits over the trailing month and 15-40% below their 52-week highs, consistent with a significant market correction or risk-off event. However, a clear pocket of strength has emerged in AI-linked semiconductors, cybersecurity, and life-science instrument makers, several of which are back within a few percent of their 52-week highs with strong 5-day and 30-day returns, suggesting a rotation into quality growth names even as the index broadly de-rates.

AI/semiconductor momentum leaders (META, AMD, INTC, NVDA, MU) decoupling from a broadly weak marketCybersecurity names (CRWD, PANW, FTNT) near 52-week highs on sustained multi-week strengthLife-science instrument and diagnostics stocks (TMO, A, WAT, MTD, RVTY, IQV, DHR) showing steady uptrends near highsBroad index-wide stress: most S&P 500 constituents down 10-30% on the month and well off 52-week highs

Today's Actionable List

Which of today's picks to actually take, and at what size, given what you are already holding. Each pick's own Suggested Allocation sizes it in isolation; this table applies the portfolio limits — at most 20 open positions and 60% of the portfolio committed in total. Run with --capital 25000 to see these sizes as order amounts rather than percentages.

0 of 4
0%
60 · 301.2%
301.2% / 60%
0 of 20
RankStockActionSizeEntry → TargetNotes
#1 DHR SKIP — $222.69 → $234.06
stop $203.54
Half-Kelly sizes this at 0% — the odds carry no edge worth capital.
#2 INTC SKIP — $124.48 → $131.10
stop $111.53
Half-Kelly sizes this at 0% — the odds carry no edge worth capital.
#3 FTNT SKIP — $179.31 → $189.07
stop $162.45
Half-Kelly sizes this at 0% — the odds carry no edge worth capital.
#4 IQV SKIP — $272.95 → $286.60
stop $254.12
Position cap reached — 60 of 20 slots in use.

Already open: GILD (to Sep 25), ANET (to Sep 26), AMZN (to Sep 26), MSFT (to Sep 27), IMI.L (to Sep 30), NOW (to Oct 1), HSX.L (to Oct 1), LSEG.L (to Oct 1), ADM (to Oct 2), MCK (to Oct 2), BEZ.L (to Oct 2), BIIB (to Oct 3) … and 48 more. Symbols you already hold were excluded from this run's candidates rather than re-picked.

Position-sizing guidance only — half-Kelly per pick, bounded by the limits above. Not personal investment advice.

Behind the scenes: how each AI analyst did
Aria
6 picks
Blaze
5 picks
Nova
2 picks
Orion
4 picks
Quinn
7 picks

4 Stock Picks

Sector concentration cap applied: 1 lower-ranked pick removed to keep at most 2 picks per sector (ILMN), so the final list isn't over-concentrated in one sector.
#1 DHRDanaher Corporation
5/5 Agents Agree  Risk 5/10  ⚠ Conflicting Signals  ⚠ Earnings in Window
Moderate conviction · 56%

Danaher makes lab and diagnostic instruments used by hospitals and biotech researchers, another name benefiting from the current rotation into life-sciences equipment makers. Its price recently accelerated (+6% in just five days) and is trading above both its short- and long-term trend lines, with a solid four-quarter earnings-beat streak. The key risk is that its overall outperformance versus the market is the thinnest of this group, so it has less of a buffer if the broader selloff resumes.

Stop-loss$203.54-8.6%
Today's price$222.69
Target$234.06+5.1%
Agents estimate: $234.30 (+0.1% vs target)
If you invested $1,000
▲$1,051 if the target hits (+5.1%)
▼$914 if the stop-loss is hit (-8.6%)
The AI puts the chance of the win case at 56%. Not a guarantee — always set the stop-loss.

Why the AI likes it

What could go wrong

⚔ The Skeptic's View — Sage, the Devil's Advocate
  • OBV of -8,137,313 is negative even as price rallied 6.88% over 5 days, a bearish volume divergence suggesting the move is not backed by accumulation despite the bulls' technical-strength framing.
  • Price at $222.69 is pressing directly against the upper Bollinger Band ($222.79), leaving little room for further near-term upside before a mean-reversion pullback toward the $210.61 mid-band.
Show the detailed analysis

Calibrated probability: 56% (raw model estimate: 64%) — adjusted using the accuracy of past resolved picks.

Trade math

0.6:1
63%
+0.2%
0%

Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.

What each AI analyst estimated

Aria
72%
Very High
Blaze
69%
High
Nova
53%
Medium
Orion
63%
High
Quinn
60%
Medium
#2 INTCIntel Corporation
5/5 Agents Agree  Risk 5/10  ⚠ Conflicting Signals  ⚠ Earnings in Window
Moderate conviction · 56%

Intel makes computer chips and is trying to rebuild its manufacturing business to compete with rivals like TSMC. The company just posted its strongest revenue growth in over 15 years and blew past Wall Street's profit estimate, and the CEO personally bought $10 million of stock. The main risk is that Intel reports its next earnings before this trade would close, which adds an all-or-nothing news event to the mix.

Stop-loss$111.53-10.4%
Today's price$124.48
Target$131.10+5.3%
Agents estimate: $131.51 (+0.3% vs target)
If you invested $1,000
▲$1,053 if the target hits (+5.3%)
▼$896 if the stop-loss is hit (-10.4%)
The AI puts the chance of the win case at 56%. Not a guarantee — always set the stop-loss.

Why the AI likes it

What could go wrong

⚔ The Skeptic's View — Sage, the Devil's Advocate
  • RSI of 71.57 is in overbought territory, not merely 'healthy strength' — combined with a 42.65% 30-day and 18.64% 5-day surge, this is a classic blow-off/overextension setup prone to sharp mean reversion.
  • Price ($124.48) is already testing the upper Bollinger Band ($126.66), and a single CEO purchase of $10M is small relative to Intel's market cap, offering little cushion against profit-taking after a 43% run.
Show the detailed analysis

Calibrated probability: 56% (raw model estimate: 65%) — adjusted using the accuracy of past resolved picks.

Trade math

0.5:1
66%
-0.2%
0%

Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.

What each AI analyst estimated

Aria
65%
High
Blaze
82%
Very High
Nova
53%
Medium
Orion
58%
Medium
Quinn
62%
High
#3 FTNTFortinet, Inc.
4/5 Agents Agree  Risk 4/10  ⚠ Conflicting Signals
Strong conviction · 60%

Fortinet sells cybersecurity hardware and software that businesses use to protect their networks. The stock is trending strongly higher, beating the broader market by a wide margin, and its price is holding above its key moving averages with healthy (not overheated) momentum. The main risk is that several top executives, including the CEO, have been selling a lot of stock recently, which can sometimes signal they think shares are fully valued.

Stop-loss$162.45-9.4%
Today's price$179.31
Target$189.07+5.4%
Agents estimate: $189.86 (+0.4% vs target)
If you invested $1,000
▲$1,054 if the target hits (+5.4%)
▼$906 if the stop-loss is hit (-9.4%)
The AI puts the chance of the win case at 60%. Not a guarantee — always set the stop-loss.

Why the AI likes it

What could go wrong

⚔ The Skeptic's View — Sage, the Devil's Advocate
  • RSI of 65.42 combined with price sitting just 1.13% below the 52-week high and near the upper Bollinger Band ($182.26 vs. $179.31 price) suggests the rally is stretched and has limited room before hitting resistance at the prior high.
  • The 5-day momentum has already decelerated sharply to +5.62% from a 30-day pace implying much faster gains, hinting the strongest part of the move may be behind it.
Show the detailed analysis

Calibrated probability: 60% (raw model estimate: 71%) — adjusted using the accuracy of past resolved picks.

Trade math

0.6:1
63%
+1.1%
0%

Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.

What each AI analyst estimated

Aria
75%
Very High
Blaze
81%
Very High
Nova
—
—
No stock-specific catalyst appeared in the news feed — only generic market headlines were returned — and insiders including the CEO have been selling.
Orion
66%
High
Quinn
60%
Medium
#4 IQVIQVIA Holdings Inc.
3/5 Agents Agree  Risk 4/10  ⚠ Conflicting Signals
Strong conviction · 60%

IQVIA runs clinical trials and data analytics for pharmaceutical companies, part of the life-sciences pocket of strength holding up while the broader market slides. Its price is squeezed tightly between technical support and resistance, which often precedes a breakout move, and it's trading above its key moving averages. The main risks are that its recent outperformance versus the market is thinner than other picks, and its momentum indicator (MACD) is showing early signs of losing steam.

Stop-loss$254.12-6.9%
Today's price$272.95
Target$286.60+5.0%
Agents estimate: $286.57 (0.0% vs target)
If you invested $1,000
▲$1,050 if the target hits (+5.0%)
▼$931 if the stop-loss is hit (-6.9%)
The AI puts the chance of the win case at 60%. Not a guarantee — always set the stop-loss.

Why the AI likes it

What could go wrong

⚔ The Skeptic's View — Sage, the Devil's Advocate
  • MACD histogram is negative (-0.6789), a bearish crossover signal that directly contradicts the momentum narrative even as RSI stays elevated at 65.73.
  • OBV of -11,083,441 is negative despite the price gain, indicating volume is not confirming the rally — a divergence that undercuts the bullish breakout read on the Bollinger squeeze.
Show the detailed analysis

Calibrated probability: 60% (raw model estimate: 70%) — adjusted using the accuracy of past resolved picks.

Trade math

0.7:1
58%
+1.4%
8.5%

Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.

What each AI analyst estimated

Aria
72%
Very High
Blaze
81%
Very High
Nova
—
—
The recent move is modest (under 5% in a month) on below-average trading volume, too weak to treat as a fresh catalyst-driven breakout.
Orion
—
—
A contract research/commercial-services provider rather than an instrument maker, plus a much weaker 30-day return (under 5%) and a slightly bearish MACD histogram, so it lacked the same tailwind confirmation and technical strength as its peers.
Quinn
55%
Medium

Retail Investor Execution Guide

This report identifies stocks with an AI-assessed probability of gaining +5% within 30 calendar days (target exit by October 24, 2026). Picks are ranked by how many independent AI agents agreed — more agreement means higher conviction. The guide below tells you exactly how to act on them.

Step-by-Step Action Plan

  1. Act within one trading day. Prices are freshest now. The longer you wait, the more the entry price drifts away from what the agents analysed.
  2. Verify the entry price. Check the live price before buying. If a stock has already moved more than 3% above the Current Price shown in the report, skip it or wait for a pullback — the risk/reward has shifted.
  3. Use limit orders, not market orders. Set your buy limit at or below the Current Price shown. Chasing with a market order gives brokers and algorithms an advantage over you.
  4. Set your stop-loss immediately after buying. Use the Max Downside % on each pick card as your hard exit level. If the price falls to that level, sell without hesitation — the trade thesis is broken.
  5. Set a take-profit at the Target Price. Place a limit sell order at the Target Price shown. When it fills, the trade is done — resist the urge to hold for more.
  6. Exit all positions by October 24, 2026. This is your hard deadline. If a stock has not hit its target by then, exit anyway. Holding past the window turns a short-term trade into an unsupervised long-term position.
  7. Never add to a losing position. If your stop-loss is hit, exit completely. Averaging down turns a small, controlled loss into a potentially large one.

Position Sizing by Conviction Tier

Size each position according to the coloured border on its pick card. Cap your total exposure across all picks from this report at 25% of your overall trading budget.

Agents Agreeing What It Means Max Allocation Per Pick
5/5 Highest conviction — all five independent analytical checks passed Up to 10%
4/5 Very high conviction — four of five independent checks aligned Up to 8%
3/5 High conviction — three agents independently agreed Up to 6%
2/5 Moderate conviction — two agents independently agreed Up to 4%
1 Agent Speculative — solo pick, admitted only at Very High confidence Up to 2%

The Three Exit Rules

These picks are generated by AI agents for informational and educational purposes only. They do not constitute financial advice or a recommendation to buy or sell any security. Probability estimates reflect the agents' analytical models — they are not guarantees of any outcome. Past results are not indicative of future performance. Markets can and do move against even well-researched trades. Always conduct your own research, and consider seeking advice from a licensed financial adviser before placing any orders. Never invest money you cannot afford to lose.

Understanding the Numbers

A plain-English guide to every figure shown on each pick card — what it means, how it is calculated, and what a good or bad value looks like.

AI Conviction Meter
Estimated probability of hitting the target, shown as a 5-bar gauge
The filled bars and label translate the AI's probability estimate into plain language: 75%+ is Very strong, 60–74% Strong, 50–59% Moderate, below 50% Cautious. Where enough past picks have been resolved, the probability is calibrated against the AI's real track record.
e.g. "Moderate conviction · 58%" — the AI thinks this trade works slightly more often than a coin flip.
✓ More filled bars = more confidence — but even Very strong picks fail sometimes; always size positions accordingly.
If You Invested $1,000
$1,000 × (1 + Target Gain ÷ 100)  /  $1,000 × (1 + Max Downside ÷ 100)
The same Target Gain and Max Downside percentages expressed in concrete money terms for a $1,000 position — what you'd have if the target hits versus if your stop-loss is triggered.
e.g. +10% target and −12.3% stop → $1,100 on a win, $877 on a stopped-out loss.
✓ Scales linearly — a $500 position sees half these amounts, a $2,000 position double.
Current Price
Market price at time of analysis
The stock's price when this report was generated. All other figures on the card are calculated from this reference point.
e.g. $215.20 — check the live price before placing an order; if it has moved more than ~3%, re-evaluate the risk/reward.
✓ No positive/negative distinction — it is simply your cost basis.
Target Price
Current Price × (1 + Target Gain ÷ 100)
The price the agents project the stock could reach within the time window. This is your take-profit level — place a limit sell order here after buying.
e.g. $215.20 × 1.085 = $233.49 target on an 8.5% pick.
✓ Always above Current Price — this tool only selects upside candidates.
Target Gain
(Target Price − Current Price) ÷ Current Price × 100
The percentage return you would earn if the stock hits its Target Price from your entry. Set by the run parameters — every pick in this report targets the same percentage.
e.g. +8.5% means a $100 stock has a $108.50 target; a $500 stock has a $542.50 target.
✓ Always positive — picks are upside-only. A larger % means a bigger move is required.
Max Downside
Estimated stop-loss level, as % below entry
The worst-case loss the agents estimated if the thesis fails — based on key support levels and recent volatility. Use this as your hard stop-loss. If the price falls to this level, exit immediately; the trade thesis is broken.
e.g. −12.0% means: if you bought at $100, sell if it drops to $88.00.
⚠ Always negative. A smaller magnitude (e.g. −5%) = tighter risk. A larger magnitude (e.g. −20%) = more room to fall before you exit — riskier.
Reward : Risk
Target Gain ÷ |Max Downside|
How much you could gain for every dollar you are risking. A ratio of 2.0:1 means you stand to make $2 for every $1 at risk. Higher is better.
e.g. 8.5% gain ÷ 12% downside = 0.7:1 (unfavourable). 10% gain ÷ 5% downside = 2.0:1 (good).
✓ ≥ 2.0:1 is strong. ⚠ < 1.0:1 means you are risking more than you could gain — approach with caution.
Breakeven Win Rate
|Max Downside| ÷ (Target Gain + |Max Downside|) × 100
The minimum percentage of trades at this reward:risk that must succeed for you to break even over time — regardless of how good your stock picking is.
e.g. 12 ÷ (8.5 + 12) = 59% — you need roughly 6 in 10 trades to win just to avoid losing money.
✓ Lower is better — ≤ 35% means even a poor win rate is survivable. ⚠ ≥ 55% means you need most trades to work out.
Expected Value
(Probability% × Target Gain%) + ((1 − Probability%) × Max Downside%)
The average return per trade if the AI's probability estimate is accurate over many similar trades. A positive Expected Value means the trade has a mathematical edge; a negative value means the math works against you on average, even if you sometimes win.
e.g. 65% × +8.5% + 35% × −12% = +1.3% EV. Over 100 similar trades you would expect an average gain of 1.3% per trade.
✓ Positive = edge in your favour over many trades. ⚠ Negative = the math loses money on average — even if individual wins feel good. Note: EV is only as reliable as the probability estimate.
Suggested Allocation
half-Kelly: (Probability ÷ |Max Downside| − (1 − Probability) ÷ Target Gain) ÷ 2, capped at 10%
The Kelly criterion computes the portfolio fraction that maximises long-run growth for a bet with these odds; half-Kelly is the standard hedge against the probability estimate being too optimistic. Uses the calibrated probability where available. 0% means the math sees no edge worth sizing; — means it couldn't be computed.
e.g. 57% probability, +10% target, −13% downside → Kelly ≈ 8.5% of portfolio, half-Kelly ≈ 4.2%.
Generic sizing guidance only — not personal investment advice. Position sizing must reflect your own portfolio, risk tolerance and circumstances.
Every stock Scout considered — and why each was discarded

Scout scanned 503 S&P 500 constituents and short-listed 25 candidates for deep analysis by the five analysts. Here is what happened to each one.

  • METAMeta Platforms, Inc.Dropped at merge
    Scout: Up 38% over 30 days and only 0.2% off its 52-week high with continued 5-day strength, showing the strongest sustained momentum in the index.
    Only Quinn selected this stock — Quinn solo picks require High or Very High confidence and at least 60% probability (this pick: Medium, 55% raw (48% after calibration)).
  • AMDAdvanced Micro Devices, Inc.Already held
    Scout: 35% 30-day gain with price just 1.7% off its 52-week high, reflecting strong sustained AI-chip demand momentum.
    Already held: a position opened 2026-09-21 runs until 2026-10-21 (28 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • NVDANVIDIA CorporationAlready held
    Scout: Steady 7% 30-day gain and only 5.5% below its 52-week high, holding up as an AI-capex bellwether while peers slump.
    Already held: a position opened 2026-09-22 runs until 2026-10-22 (28 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • INTCIntel CorporationPicked #2
    Scout: Explosive 43% 30-day and 14% 5-day gains signal a strong turnaround narrative, though still ~13% below its high leaves room to run.
    Made the final report at #2.
  • MUMicron Technology, Inc.Already held
    Scout: 17% 30-day gain with continued 9% 5-day strength on the memory-chip upcycle theme.
    Already held: a position opened 2026-09-22 runs until 2026-10-22 (28 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • SWKSSkyworks Solutions, Inc.Already held
    Scout: Sharp 33% 30-day rally now trading only 4.4% below its 52-week high, indicating durable buying interest.
    Already held: a position opened 2026-09-17 runs until 2026-10-17 (23 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • CRWDCrowdStrike Holdings, Inc.Already held
    Scout: 37% 30-day gain and just 1.1% off its 52-week high shows cybersecurity demand momentum staying intact.
    Already held: a position opened 2026-09-23 runs until 2026-10-23 (30 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • PANWPalo Alto Networks, Inc.Already held
    Scout: 11% 30-day gain with price only 2% off its 52-week high, consistent uptrend in a defensive-growth security name.
    Already held: a position opened 2026-09-16 runs until 2026-10-16 (22 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • FTNTFortinet, Inc.Picked #3
    Scout: 18% 30-day gain and just over 1% from its 52-week high, one of the steadier cybersecurity momentum plays.
    Made the final report at #3.
  • TMOThermo Fisher Scientific Inc.Already held
    Scout: 7% 30-day gain within 1% of its 52-week high, a defensive life-sciences name showing renewed strength.
    Already held: a position opened 2026-09-17 runs until 2026-10-17 (23 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • AAgilent Technologies, Inc.Already held
    Scout: Nearly 12% gain over both 5 and 30 days, less than 1% from its 52-week high — one of the strongest instrument-maker trends in the data.
    Already held: a position opened 2026-09-22 runs until 2026-10-22 (28 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • WATWaters CorporationAlready held
    Scout: Consistent uptrend, up 4.6% on the month and only 1.6% off its 52-week high.
    Already held: a position opened 2026-09-16 runs until 2026-10-16 (22 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • MTDMettler-Toledo International Inc.Liquidity filter
    Scout: 10% 5-day surge and 8% 30-day gain, trading near its 52-week high in the lab-instruments group.
    20-day average daily volume 202,840 shares is below the 500,000-share liquidity floor.
  • RVTYRevvity, Inc.Already held
    Scout: 19% 30-day gain with price only 1.8% below its 52-week high, showing durable strength in diagnostics/life sciences.
    Already held: a position opened 2026-09-16 runs until 2026-10-16 (22 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • IQVIQVIA Holdings Inc.Picked #4
    Scout: Steady gains across both windows and just 1.6% from its 52-week high, a defensive CRO name holding up well.
    Made the final report at #4.
  • DHRDanaher CorporationPicked #1
    Scout: 7% 5-day pop and 3.5% 30-day gain in the recovering life-sciences equipment group.
    Made the final report at #1.
  • AAPLApple Inc.Already held
    Scout: 8.6% 30-day gain and only 2.4% off its 52-week high, showing megacap resilience amid the broader selloff.
    Already held: a position opened 2026-09-22 runs until 2026-10-22 (28 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • ANETArista Networks, Inc.Already held
    Scout: 8.5% 30-day gain and only 5% off its 52-week high on continued AI-networking demand.
    Already held: a position opened 2026-08-27 runs until 2026-09-26 (3 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • MRNAModerna, Inc.Dropped at merge
    Scout: Standout 33% 30-day and 17% 5-day gains, nearing its 52-week high after a strong catalyst-driven run.
    Reward-to-risk 0.37 is below the 0.50 minimum — a +5.00% target against a -13.6% stop.
  • GILDGilead Sciences, Inc.Already held
    Scout: Modest but steady gains across both windows, trading just 4% off its 52-week high with defensive biotech characteristics.
    Already held: a position opened 2026-08-26 runs until 2026-09-25 (1 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • PLTRPalantir Technologies Inc.Already held
    Scout: 9% gains across both 5- and 30-day windows and only 7.5% off its 52-week high, sustaining its AI-software momentum.
    Already held: a position opened 2026-09-23 runs until 2026-10-23 (30 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • HPEHewlett Packard Enterprise CompanyAlready held
    Scout: 21% 30-day gain and just 1.6% off its 52-week high, showing a sharp re-rating in enterprise/AI infrastructure hardware.
    Already held: a position opened 2026-09-21 runs until 2026-10-21 (28 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • WBDWarner Bros. Discovery, Inc.Dropped at merge
    Scout: Nearly 10% 5-day and 7% 30-day gains, trading within 0.4% of its 52-week high on active M&A/restructuring speculation.
    Only Quinn selected this stock — Quinn solo picks require High or Very High confidence and at least 60% probability (this pick: Medium, 60% raw (56% after calibration)).
  • KEYSKeysight Technologies, Inc.Already held
    Scout: 14% 30-day and 10% 5-day gains, only 5% off its 52-week high in the test-and-measurement space.
    Already held: a position opened 2026-09-23 runs until 2026-10-23 (30 day(s) left). Re-picking it would concentrate the portfolio, not diversify it.
  • ILMNIllumina, Inc.Passed over
    Scout: 20% 30-day and 17% 5-day surge, trading just 0.3% from its 52-week high — one of the strongest reversals in the dataset.
    Nova: No stock-specific catalyst appeared in the news despite a 20% rally; the stock is overbought (RSI 75) and a major director has sold a very large amount of stock.
    Quinn: Price has risen sharply but on-balance volume shows divergence from price, meaning the rally isn't backed by matching volume, which typically signals an unsustainable move; combined with an overbought RSI, this pulls the computed probability down to the floor with weak confidence.

Agent Analytical Approaches

Aria

Momentum & Technical

Checks 30-day price history for every candidate before making any selection. Requires positive period return and positive 5-day momentum as mandatory gates. Ranks picks by proximity to their period high and adjusts probability based on volume. Uses news only to rule out major negative catalysts.

Blaze

Fundamental & Earnings

Searches earnings results, analyst upgrades, and revenue trends before checking price data. Requires at least one verifiable fundamental catalyst — earnings beat, analyst upgrade, or revenue acceleration — within the last 60 days. Favours stocks with strong fundamentals trading below recent highs (value entry).

Nova

News Catalyst & Event-Driven

Hunts for specific events within the last 21 days: FDA approvals, major contract wins, product launches, earnings surprises, or significant analyst upgrades. Requires a positive price reaction confirming the market is recognising the catalyst. Also scans for upcoming events that could drive further gains.

Orion

Macro & Sector Rotation

Maps the macroeconomic regime (risk-on / risk-off / neutral) and identifies sectors benefiting from current conditions before looking at individual stocks. Only selects stocks from macro-aligned sectors with confirmed sector tailwinds. Adjusts for interest rate sensitivity and geopolitical factors.

Sage

Devil's Advocate

Reviews the final picks after all four analysts agree and actively challenges each bull thesis. Searches for bearish technical signals, negative news, insider selling, and elevated short interest that the agreeing agents may have underweighted. Produces evidence-based counter-arguments shown on each pick card.

Quinn

Quantitative / Statistical

Pure-quant analyst: no news, no narrative, only numbers. Identifies mean-reversion setups from RSI extremes (<35) with momentum turning, Bollinger squeeze breakouts, and multi-factor quant scores using RSI, MACD, OBV, short interest, and insider transaction data. Counterbalances narrative bias across the four analyst agents.